UPL Ltd (UPL) — shareholding pattern, promoter holding, financials and share price
About UPL Ltd (UPL)
UPL Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as UPL and on the BSE under scrip code 512070. Its ISIN is INE628A01036.
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
UPL Limited is a global leader in the agro-business industry, focusing on the production and sale of agrochemicals, field crops, vegetable seeds, and industrial chemicals.
In Q3 FY26, UPL reported a 12% year-over-year increase in revenue, driven by an 8% increase in volumes and beneficial foreign exchange impacts despite pricing pressures.
Listed peers in Pesticides & Agrochemicals: P I Industries Ltd, Sumitomo Chemical India Ltd, Bayer CropScience Ltd, Sharda Cropchem Ltd, NACL Industries Ltd, Dhanuka Agritech Ltd.
Valuation & Returns
10 Jul 2026At ₹594.65 a share on 10 Jul 2026, UPL Ltd (UPL) was valued at a price-to-earnings ratio of 22.61x against an industry P/E of 22.12x and a price-to-book of 1.72x on a book value of ₹346.06 per share as of Mar 2025. Solomo computes return on equity of 7.6% and return on capital employed of 12.07% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 22.61x
- Industry P/E
- 22.12x
- P/B
- 1.72x
- EPS (TTM)
- ₹26.3
- Book value / share
- ₹346.06
- ROE
- 7.6%
- ROCE
- 12.07%
- ROA
- 2.52%
- Debt / equity
- 0.86x
- Dividend yield
- 1.01%
- EBITDA margin
- 18.91%
- 52-week range
- ₹563.25 – ₹812
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, UPL Ltd (UPL) reported revenue of ₹51,839 crore, net profit of ₹2,220 crore and earnings per share of ₹22.78. That compares with revenue of ₹46,637 crore and net profit of ₹820 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹18,335 crore and net profit ₹1,294 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 46,240 | 53,576 | 43,098 | 46,637 | 51,839 |
| Net profit (₹ cr) | 4,437 | 4,414 | -1,878 | 820 | 2,220 |
| EPS (₹) | 42.18 | 42.28 | -14.21 | 10.62 | 22.78 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -1.80% | -11.18% | -31.31% | 8.21% |
| Profit growth | 15.80% | 41.80% | 30.99% | 143.66% |
| Stock price CAGR | 6% | -5% | 0% | -7% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 33.51% of UPL Ltd (UPL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 43.71% and domestic institutional investors (DII) hold 14.32%. Market capitalisation was ₹50,199 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: ICICI Prudential India Opportunities Fund 3.69%, Life Insurance Corporation Of India 3.48%, SBI Contra Fund 1.86%, MFS International Growth Fund 1.66%, Pzena Emerging Markets Value Fund 1.49%, JP Morgan Chase Bank, NA 1.32%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 33.51% | - | 43.71% | 14.32% | 66.49% |
| Mar 2026 | 33.51% | - | 43.1% | 14.63% | 66.49% |
| Dec 2025 | 33.5% | - | 40.99% | 16.72% | 66.5% |
| Sep 2025 | 33.5% | - | 39.88% | 17.16% | 66.5% |
| Jun 2025 | 33.5% | - | 37.82% | 18.1% | 66.5% |
| Mar 2025 | 33.5% | - | 37.21% | 18.56% | 66.5% |
| Dec 2024 | 33.51% | - | 35.46% | 18.89% | 66.49% |
| Sep 2024 | 32.52% | 0.9% | 37.53% | 17.65% | 67.48% |